Tessa Therapeutics Ltd., of Singapore, appointed Jeffrey H. Buchalter CEO and Göran A. Ando chair of its board. Buchalter joined Tessa’s board in March 2019. He previously served in various chairmanships and as CEO of Archimedes Pharma Ltd., Enzon Pharmaceuticals Inc. and Ilex Oncology Inc. Ando joined the company’s board in April 2018. He currently serves as board chair for Eyepoint Pharmaceuticals Inc. and has been a senior adviser to Essex Woodlands since 2007.

No Comments